Effects of Long-Term Administration of Caffeine in a Mouse Model for Alzheimer’s Disease
A recent epidemiological study suggested that higher caffeine intake reduces the risk of Alzheimer's disease (AD). Caffeine, a widely consumed stimulatory drug, is a non-selective adenosine receptor antagonist that has been shown to increase plasma adenosine levels in rodents. To determine any...
Main Author: | Schleif, William |
---|---|
Format: | Others |
Published: |
Scholar Commons
2005
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/854 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=1853&context=etd |
Similar Items
-
On the Involvement of the Low-Density Lipoprotein Receptor in the Pathogenesis and Progression of Alzheimer’s Disease
by: Abisambra Socarras, Jose Francisco
Published: (2009) -
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
by: Monica Garcia-Alloza, et al.
Published: (2006-12-01) -
The Aβ Containing Brain Extracts Having Different Effects in Alzheimer’s Disease Transgenic Caenorhabditis elegans and Mice
by: Yufang Yang, et al.
Published: (2018-07-01) -
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
by: Oliver Wirths, et al.
Published: (2020-10-01) -
Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease
by: M. Coma, et al.
Published: (2010-06-01)